← Back to all trials
Completed
NCT07746739
Efficacy of Platelet Rich Plasma on Pelvic Floor Muscle Strength and Recurrence Rate in Pelvic Organ Prolapse Surgery
Conditions: Pelvic Organ Prolapse Vaginal Surgery, Pelvic Organ Prolapse, Platelet Rich Plasma Injection
Sex: Female
Ages: 65 Years – N/A
Healthy volunteers: No
Phase: NA
Enrollment: 40
Sponsor: Andalas University
Location: M Djamil Hospital Padang West Sumatera
Summary
Pelvic organ prolapse (POP) is a common pelvic floor disorder associated with impaired quality of life and considerable postoperative recurrence following native tissue repair. Platelet-rich plasma (PRP) has emerged as a regenerative adjunct to improve tissue healing and surgical outcomes.
Objective: To evaluate the effect of adjuvant PRP on pelvic floor muscle A single-blind randomized controlled trial was conducted involving 40 women with stage II or higher POP who were randomly assigned to surgery with adjuvant PRP (n=20) or surgery alone (n=20). Pelvic floor muscle strength was assessed by perineometry, while anatomical outcomes were evaluated using the Pelvic Organ Prolapse Quantification (POP-Q) system 8 weeks postoperatively.
Eligibility Criteria
Inclusion Criteria: women aged ≤65 years with stage II or higher pelvic organ prolapse (POP) who provided written informed consent to participate
Exclusion Criteria:a history of gynecologic malignancy, collagen vascular disease, hematological disorders, or diabetes mellitus.
Source: ClinicalTrials.gov (NCT07746739). StuddyBuddy aggregates publicly available trial information.